Characterization of a multicenter pediatric-hydrocephalus shunt biobank.
Biobank
CSF = cerebrospinal fluid
Hydrocephalus
Improving surgical outcomes
Multicenter
Retrospective cohort
Shunt failure
Shunt obstruction
Translational
Ventriculoperitoneal shunt
Journal
Fluids and barriers of the CNS
ISSN: 2045-8118
Titre abrégé: Fluids Barriers CNS
Pays: England
ID NLM: 101553157
Informations de publication
Date de publication:
18 Jul 2020
18 Jul 2020
Historique:
received:
03
05
2020
accepted:
13
07
2020
entrez:
20
7
2020
pubmed:
20
7
2020
medline:
4
5
2021
Statut:
epublish
Résumé
Pediatric hydrocephalus is a devastating and costly disease. The mainstay of treatment is still surgical shunting of cerebrospinal fluid (CSF). These shunts fail at a high rate and impose a significant burden on patients, their families and society. The relationship between clinical decision making and shunt failure is poorly understood and multifaceted, but catheter occlusion remains the most frequent cause of shunt complications. In order to investigate factors that affect shunt failure, we have established the Wayne State University (WSU) shunt biobank. To date, four hospital centers have contributed various components of failed shunts and CSF from patients diagnosed with hydrocephalus before adulthood. The hardware samples are transported in paraformaldehyde and transferred to phosphate-buffered saline with sodium azide upon deposit into the biobank. Once in the bank, they are then available for study. Informed consent is obtained by the local center before corresponding clinical data are entered into a REDCap database. Data such as hydrocephalus etiology and details of shunt revision history. All data are entered under a coded identifier. 293 shunt samples were collected from 228 pediatric patients starting from May 2015 to September 2019. We saw a significant difference in the number of revisions per patient between centers (Kruskal-Wallis H test, p value < 0.001). The leading etiology at all centers was post-hemorrhagic hydrocephalus, a fisher's exact test showed there to be statistically significant differences in etiology between center (p = 0.01). Regression showed age (p < 0.01), race (p = 0.038) and hospital-center (p < 0.001) to explain significant variance in the number of revisions. Our model accounted for 31.9% of the variance in revisions. Generalized linear modeling showed hydrocephalus etiology (p < 0.001), age (p < 0.001), weight and physician (p < 0.001) to impact the number of ventricular obstructions. The retrospective analysis identified that differences exist between currently enrolled centers, although further work is needed before clinically actionable recommendations can be made. Moreover, the variables collected from this chart review explain a meaningful amount of variance in the number of revision surgeries. Future work will expand on the contribution of different site-specific and patient-specific factors to identify potential cause and effect relationships.
Sections du résumé
BACKGROUND
BACKGROUND
Pediatric hydrocephalus is a devastating and costly disease. The mainstay of treatment is still surgical shunting of cerebrospinal fluid (CSF). These shunts fail at a high rate and impose a significant burden on patients, their families and society. The relationship between clinical decision making and shunt failure is poorly understood and multifaceted, but catheter occlusion remains the most frequent cause of shunt complications. In order to investigate factors that affect shunt failure, we have established the Wayne State University (WSU) shunt biobank.
METHODS
METHODS
To date, four hospital centers have contributed various components of failed shunts and CSF from patients diagnosed with hydrocephalus before adulthood. The hardware samples are transported in paraformaldehyde and transferred to phosphate-buffered saline with sodium azide upon deposit into the biobank. Once in the bank, they are then available for study. Informed consent is obtained by the local center before corresponding clinical data are entered into a REDCap database. Data such as hydrocephalus etiology and details of shunt revision history. All data are entered under a coded identifier.
RESULTS
RESULTS
293 shunt samples were collected from 228 pediatric patients starting from May 2015 to September 2019. We saw a significant difference in the number of revisions per patient between centers (Kruskal-Wallis H test, p value < 0.001). The leading etiology at all centers was post-hemorrhagic hydrocephalus, a fisher's exact test showed there to be statistically significant differences in etiology between center (p = 0.01). Regression showed age (p < 0.01), race (p = 0.038) and hospital-center (p < 0.001) to explain significant variance in the number of revisions. Our model accounted for 31.9% of the variance in revisions. Generalized linear modeling showed hydrocephalus etiology (p < 0.001), age (p < 0.001), weight and physician (p < 0.001) to impact the number of ventricular obstructions.
CONCLUSION
CONCLUSIONS
The retrospective analysis identified that differences exist between currently enrolled centers, although further work is needed before clinically actionable recommendations can be made. Moreover, the variables collected from this chart review explain a meaningful amount of variance in the number of revision surgeries. Future work will expand on the contribution of different site-specific and patient-specific factors to identify potential cause and effect relationships.
Identifiants
pubmed: 32682437
doi: 10.1186/s12987-020-00211-6
pii: 10.1186/s12987-020-00211-6
pmc: PMC7368709
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
45Subventions
Organisme : NINDS NIH HHS
ID : R01NS094570
Pays : United States
Références
J Neurosurg. 2015 Dec;123(6):1427-38
pubmed: 26090833
Pediatr Neurol. 2011 Aug;45(2):67-71
pubmed: 21763944
J Neurosurg. 2007 Nov;107(5 Suppl):345-57
pubmed: 18459897
J Neurosurg Pediatr. 2012 Mar;9(3):242-58
pubmed: 22380952
Pediatr Neurol. 2015 Mar;52(3):320-5
pubmed: 25542767
J Pediatr Surg. 2019 Nov;54(11):2439-2442
pubmed: 31130348
J Pediatr. 2018 Sep;200:24-29.e3
pubmed: 29754865
Surg Neurol Int. 2013 Mar 19;4(Suppl 1):S38-50
pubmed: 23653889
J Neurosurg Pediatr. 2008 Feb;1(2):131-7
pubmed: 18352782
J Transl Med. 2019 Apr 23;17(1):133
pubmed: 31014363
Neurosurgery. 2005;56(1):139-44; discussion 144-5
pubmed: 15617596
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Neurosurgery. 2012 Jun;70(6):1589-601; discussion 1601-2
pubmed: 22157548
Neurosurg Rev. 1999 Oct;22(2-3):67-93; discussion 94-5
pubmed: 10547004
Clin Neurol Neurosurg. 2014 Dec;127:30-2
pubmed: 25459240
Pediatr Neurosurg. 2000 Nov;33(5):230-236
pubmed: 11155058
J Neurosurg Pediatr. 2016 Apr;17(4):391-6
pubmed: 26684763
Arch Dis Child. 1962 Aug;37:345-62
pubmed: 14462827
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Neurosurg Pediatr. 2016 Aug;18(2):213-23
pubmed: 27035548
J Neurosurg Pediatr. 2013 Oct;12(4):334-8
pubmed: 23909616
J Neurosurg. 1982 Mar;56(3):411-6
pubmed: 7057239
Eur J Pediatr. 1998 May;157(5):355-62
pubmed: 9625330